114 results
Page 2 of 6
SC14D9C
EX-99.5
jqadd6ziw8r326x
3 Oct 23
Written communication relating to third party tender offer
5:24pm
SC14D9C
EX-99.1
jyokuofwkj8v80ql7g
3 Oct 23
Written communication relating to third party tender offer
5:24pm
SC TO-C
EX-99.1
8k1dcp z7q10lpiwju
3 Oct 23
Information about tender offer
4:30pm
SC TO-C
hjpm4vt
3 Oct 23
Information about tender offer
4:30pm
SC14D9C
EX-2.1
6swnnrfe9a
3 Oct 23
Written communication relating to third party tender offer
7:37am
SC14D9C
0u7e uxoz5ydy0oguoo9
3 Oct 23
Written communication relating to third party tender offer
7:37am
SC14D9C
EX-99.4
0tsm6xy
3 Oct 23
Written communication relating to third party tender offer
7:37am
8-K
3o7rf
3 Oct 23
Tender and Support Agreement
7:35am
8-K
EX-2.1
bxtbnptfgrj8u jb4p
3 Oct 23
Tender and Support Agreement
7:35am
8-K
EX-99.4
6qqbi1fvkacb5
3 Oct 23
Tender and Support Agreement
7:35am
ARS
9isrz35
1 May 23
Annual report to shareholders
1:52pm
8-K
EX-1.1
g43pzq09acj3m
14 Sep 22
POINT Biopharma Prices Public Offering of Common Stock
4:14pm